Cash & Equivalents
Abbott Cash & Equivalents increased by 13.5% to $8.52B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.9%, from $7.62B to $8.52B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows an upward trend with a 4.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Detailed definition
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Peer comparison
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.66B | $9.30B | $9.80B | $7.68B | $8.94B | $9.59B | $9.88B | $9.16B | $7.84B | $6.71B | $6.90B | $6.28B | $6.99B | $7.56B | $7.62B | $6.53B | $6.95B | $7.51B | $8.52B |
| QoQ Change | — | +7.4% | +5.3% | -21.7% | +16.4% | +7.4% | +3.0% | -7.3% | -14.5% | -14.4% | +2.8% | -8.9% | +11.2% | +8.2% | +0.8% | -14.2% | +6.4% | +8.1% | +13.5% |
| YoY Change | — | — | — | — | +3.2% | +3.1% | +0.8% | +19.4% | -12.3% | -30.1% | -30.2% | -31.4% | -10.8% | +12.7% | +10.4% | +3.9% | -0.5% | -0.6% | +11.9% |
Cash & Equivalents at Other Companies
Frequently Asked Questions
- What is Abbott's cash & equivalents?
- Abbott (ABT) reported cash & equivalents of $8.52B in Q4 2025.
- How has Abbott's cash & equivalents changed year-over-year?
- Abbott's cash & equivalents increased by 11.9% year-over-year, from $7.62B to $8.52B.
- What is the long-term trend for Abbott's cash & equivalents?
- Over 5 years (2020 to 2025), Abbott's cash & equivalents has grown at a 4.5% compound annual growth rate (CAGR), from $6.84B to $8.52B.
- What does cash & equivalents mean?
- Money in the bank and very short-term investments that can be turned into cash almost instantly.